Literature DB >> 28978795

DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling.

Akhilesh K Singh1, Ahmet Eken1, David Hagin1, Khushbu Komal1, Gauri Bhise1, Azima Shaji1, Tanvi Arkatkar1, Shaun W Jackson1, Estelle Bettelli2, Troy R Torgerson1,3, Mohamed Oukka1,3,4.   

Abstract

Foxp3+ Tregs possess potent immunosuppressive activity, which is critical for maintaining immune homeostasis and self-tolerance. Defects in Treg development or function result in inadvertent immune activation and autoimmunity. Despite recent advances in Treg biology, we still do not completely understand the molecular and cellular mechanisms governing the development and suppressive function of these cells. Here, we have demonstrated an essential role of the dedicator of cytokinesis 8 (DOCK8), guanine nucleotide exchange factors required for cytoskeleton rearrangement, cell migration, and immune cell survival in controlling Treg fitness and their function. Treg-specific DOCK8 deletion led to spontaneous multiorgan inflammation in mice due to uncontrolled T cell activation and production of proinflammatory cytokines. In addition, we show that DOCK8-deficient Tregs are defective in competitive fitness and in vivo suppressive function. Furthermore, DOCK8 controls IL-2 signaling, crucial for maintenance and competitive fitness of Tregs, via a STAT5-dependent manner. Our study provides potentially novel insights into the essential function of DOCK8 in Tregs and immune regulation, and it explains the autoimmune manifestations associated with DOCK8 deficiency.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28978795      PMCID: PMC5841873          DOI: 10.1172/jci.insight.94275

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  59 in total

1.  IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Authors:  Matthew A Burchill; Jianying Yang; Christine Vogtenhuber; Bruce R Blazar; Michael A Farrar
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

2.  Dedicator of cytokinesis 8-deficient CD4+ T cells are biased to a TH2 effector fate at the expense of TH1 and TH17 cells.

Authors:  Stuart G Tangye; Bethany Pillay; Katrina L Randall; Danielle T Avery; Tri Giang Phan; Paul Gray; John B Ziegler; Joanne M Smart; Jane Peake; Peter D Arkwright; Sophie Hambleton; Jordan Orange; Christopher C Goodnow; Gulbu Uzel; Jean-Laurent Casanova; Saul Oswaldo Lugo Reyes; Alexandra F Freeman; Helen C Su; Cindy S Ma
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

Review 3.  DOCK8 deficiency.

Authors:  Helen C Su; Huie Jing; Qian Zhang
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

4.  Coordination of IL-7 receptor and T-cell receptor signaling by cell-division cycle 42 in T-cell homeostasis.

Authors:  Fukun Guo; David Hildeman; Pulak Tripathi; Chinavenmeni S Velu; H Leighton Grimes; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Possible mechanism for the alpha subunit of the interleukin-2 receptor (CD25) to influence interleukin-2 receptor signal transduction.

Authors:  Jonathan M Ellery; Peter J Nicholls
Journal:  Immunol Cell Biol       Date:  2002-08       Impact factor: 5.126

7.  Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.

Authors:  Andrey Antov; Lili Yang; Monika Vig; David Baltimore; Luk Van Parijs
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

8.  Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.

Authors:  Akihiko Kitoh; Masahiro Ono; Yoshinori Naoe; Naganari Ohkura; Tomoyuki Yamaguchi; Hiroko Yaguchi; Issay Kitabayashi; Toshihiko Tsukada; Takashi Nomura; Yoshiki Miyachi; Ichiro Taniuchi; Shimon Sakaguchi
Journal:  Immunity       Date:  2009-10-01       Impact factor: 31.745

9.  Novel Foxo1-dependent transcriptional programs control T(reg) cell function.

Authors:  Weiming Ouyang; Will Liao; Chong T Luo; Na Yin; Morgan Huse; Myoungjoo V Kim; Min Peng; Pamela Chan; Qian Ma; Yifan Mo; Dies Meijer; Keji Zhao; Alexander Y Rudensky; Gurinder Atwal; Michael Q Zhang; Ming O Li
Journal:  Nature       Date:  2012-11-07       Impact factor: 49.962

10.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

View more
  15 in total

Review 1.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 2.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

3.  ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients.

Authors:  Ahmet Eken; Murat Cansever; Fatma Zehra Okus; Serife Erdem; Ercan Nain; Zehra Busra Azizoglu; Yesim Haliloglu; Musa Karakukcu; Alper Ozcan; Omer Devecioglu; Guzide Aksu; Zeynep Arikan Ayyildiz; Erdem Topal; Elif Karakoc Aydiner; Ayca Kiykim; Ayse Metin; Funda Cipe; Aysenur Kaya; Hasibe Artac; Ismail Reisli; Sukru N Guner; Vedat Uygun; Gulsun Karasu; Hamiyet Dönmez Altuntas; Halit Canatan; Mohamed Oukka; Ahmet Ozen; Talal A Chatila; Sevgi Keles; Safa Baris; Ekrem Unal; Turkan Patiroglu
Journal:  Allergy       Date:  2019-10-31       Impact factor: 13.146

4.  Cutting Edge: DOCK8 Regulates a Subset of Dendritic Cells That Is Critical for the Development of Experimental Autoimmune Encephalomyelitis.

Authors:  Asanga Weliwitigoda; Pushpalatha Palle; Melissa Gessner; Nicholas W Hubbard; Mohamed Oukka; Estelle Bettelli
Journal:  J Immunol       Date:  2021-10-18       Impact factor: 5.422

5.  Retinoic acid signaling acts as a rheostat to balance Treg function.

Authors:  Govindarajan Thangavelu; Gabriela Andrejeva; Sara Bolivar-Wagers; Sujeong Jin; Michael C Zaiken; Michael Loschi; Ethan G Aguilar; Scott N Furlan; Chrysothemis C Brown; Yu-Chi Lee; Cameron McDonald Hyman; Colby J Feser; Angela Panoskaltsis-Mortari; Keli L Hippen; Kelli P MacDonald; William J Murphy; Ivan Maillard; Geoffrey R Hill; David H Munn; Robert Zeiser; Leslie S Kean; Jeffrey C Rathmell; Hongbo Chi; Randolph J Noelle; Bruce R Blazar
Journal:  Cell Mol Immunol       Date:  2022-05-17       Impact factor: 22.096

6.  Duplication of 9p24.3 in three unrelated patients and their phenotypes, considering affected genes, and similar recurrent variants.

Authors:  Zuzana Capkova; Pavlina Capkova; Josef Srovnal; Katerina Adamova; Martin Prochazka; Marian Hajduch
Journal:  Mol Genet Genomic Med       Date:  2021-01-17       Impact factor: 2.183

7.  Oral anaphylaxis to peanut in a mouse model is associated with gut permeability but not with Tlr4 or Dock8 mutations.

Authors:  Jake A Gertie; Biyan Zhang; Elise G Liu; Laura R Hoyt; Xiangyun Yin; Lan Xu; Lauren L Long; Arielle Soldatenko; Uthaman Gowthaman; Adam Williams; Stephanie C Eisenbarth
Journal:  J Allergy Clin Immunol       Date:  2021-05-27       Impact factor: 14.290

Review 8.  Transcriptional regulation of Treg homeostasis and functional specification.

Authors:  Ke Wang; Wenxian Fu
Journal:  Cell Mol Life Sci       Date:  2020-04-29       Impact factor: 9.207

Review 9.  TCR Signaling Abnormalities in Human Th2-Associated Atopic Disease.

Authors:  Joshua D Milner
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

Review 10.  Primary atopic disorders.

Authors:  Jonathan J Lyons; Joshua D Milner
Journal:  J Exp Med       Date:  2018-03-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.